LOGIN  |  REGISTER
Chimerix
Cue Biopharma

Dolby Laboratories Set to Join S&P MidCap 400; Staar Surgical to Join S&P SmallCap 600

August 17, 2023 | Last Trade: US$17.24 0.77 -4.28

NEW YORK, Aug. 17, 2023 /PRNewswire/ -- Dolby Laboratories Inc. (NYSE:DLB) will replace Staar Surgical Co. (NASD:STAA) in the S&P MidCap 400 and Staar Surgical will replace Urstadt Biddle Properties Inc. (NYSE:UBA) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, August 22. S&P 500 constituent Regency Centers Corp. (NASD: REG) will acquire Urstadt Biddle Properties in a transaction expected to close soon pending final closing conditions. Staar Surgical is more representative of the small-cap market space. 

Following is a summary of the changes that will take place prior to the open of trading on the effective date: 

Effective Date

Index Name       

Action

Company Name

Ticker

GICS Sector

August 22, 2023

S&P MidCap 400

Addition

Dolby Laboratories

DLB

Information Technology

 

S&P MidCap 400

Deletion

Staar Surgical

STAA

Health Care

 

S&P SmallCap 600

Addition

Staar Surgical

STAA

Health Care

 

S&P SmallCap 600

Deletion

Urstadt Biddle Properties

UBA

Real Estate

For more information about S&P Dow Jones Indices, please visit www.spdji.com

ABOUT S&P DOW JONES INDICES 

S&P Dow Jones Indices is the largest global resource for essential index-based concepts, data and research, and home to iconic financial market indicators, such as the S&P 500® and the Dow Jones Industrial Average®. More assets are invested in products based on our indices than products based on indices from any other provider in the world. Since Charles Dow invented the first index in 1884, S&P DJI has been innovating and developing indices across the spectrum of asset classes helping to define the way investors measure and trade the markets.

S&P Dow Jones Indices is a division of S&P Global (NYSE: SPGI), which provides essential intelligence for individuals, companies, and governments to make decisions with confidence. For more information, visit www.spdji.com.

FOR MORE INFORMATION:

S&P Dow Jones Indices
This email address is being protected from spambots. You need JavaScript enabled to view it. 

Media Inquiries
This email address is being protected from spambots. You need JavaScript enabled to view it. 

Stock Quote

Featured Stock

Cue Biopharma

Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...

CLICK TO LEARN MORE

Featured Stock

Compass Therapeutics

Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page